After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.
The Food and Drug Administration (FDA) in recent months stopped publication of studies about the safety of COVID-19 and ...
The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles ...
The studies were "withdrawn because the authors drew broad conclusions that were not supported by the underlying data," the ...
FDA officials stopped publication of studies backing COVID-19 and shingles vaccine safety, citing data concerns.
In addition, the Times learned that FDA officials did not allow agency scientists to submit two abstracts for studies on ...
In the latest update to COVID and vaccine-related discourse bubbling up at the FDA, agency officials have recently blocked ...
News of the studies being pulled comes weeks after the CDC decided it wouldn't publish a report showing last winter's covid ...
“The studies were withdrawn because the authors drew broad conclusions that were not supported by the underlying data,” HHS spokesperson Andrew Nixon said. “The FDA acted to protect the integrity of ...
The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before ...
Critics question why the federal government blocked publication of safety studies of shingles and COVID vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results